Searchable abstracts of presentations at key conferences in endocrinology

ea0063p1151 | Reproductive Endocrinology 2 | ECE2019

Psychological issues in turner syndrome

Calanchini Matilde , Fabbri Andrea , Turner Helen E

Introduction: Turner syndrome (TS) affects 1/1700 female, is due to total/partial lack of an X chromosome and besides short stature and gonadal dysgenesis, is associated with several comorbidities. No defined psychiatric condition has been related to TS. However, several case-reports have appeared in psychiatric literature, and TS is reported to be three times more prevalent in schizophrenia compared with the general female population.Aim: To evaluate th...

ea0049gp138 | Female Reproduction | ECE2017

Turner’s syndrome and abnormal liver chemistry: relationship with karyotype in a large dedicated clinic

Calanchini Matilde , Moolla Ahmad , Tomlinson Jeremy W , Cobbold Jeremy , Fabbri Andrea , Grossman Ashley , Turner Helen

Introduction: Abnormal liver function tests (↑LFTs) are frequently observed in Turner’s syndrome (TS), although the aetiology is unclear. Obesity is reported as one of the causes; recently an increased prevalence of elevated GGT was found in TS patients with a ring X karyotype.Aim: To analyse the association between abnormal LFTs and TS-related conditions, and in particular their relationship with the different TS-karyotypes.<p class="abst...

ea0049ep1145 | Female Reproduction | ECE2017

Oocyte donation in women with Turner’s syndrome: successful outcome can be achieved with a specialist multidisciplinary approach

Calanchini Matilde , Baker Kathy , Fabbri Andrea , Grossman Ashley , Orchard Elizabeth , Child Tim , Turner Helen

Introduction: Although oocyte donation (OD) is increasingly utilised in women with Turner’s syndrome (TS) few data are available. Reported clinical pregnancy rates following OD range from 17 to 40%. Complications of 2% death from aortic dissection and severe hypertension are reported.Aim: To analyse the OD-pregnancy success rate and materno-fetal outcomes in women followed in a TS-dedicated centre.Methods: A retrospective stud...

ea0046p4 | (1) | UKINETS2016

Measurement of urinary 5-hydroxyindole acetic acid: correlation between spot versus 24-hour urine collection

Calanchini Matilde , Tadman Michael , Krogh Jesper , Fabbri Andrea , Grossman Ashley , Shine Brian

Introduction: In neuroendocrine tumours (NETs), the urinary concentration of the serotonin metabolite 5-hydroxyindole acetic acid (5-HIAA) is used to monitor disease progression or treatment response. The sensitivity and specificity in the presence of the carcinoid syndrome are approximately 70 and 90%, respectively. Collecting a 24 hour urine specimen is difficult and inconvenient for patients and increases analytical variability. In addition, serotonin-containing foods may i...

ea0046p29 | (1) | UKINETS2016

Succinate dehydrogenase subunit-B mutation with associated prolactinoma and typical carcinoids

Calanchini Matilde , Shine Brian , Wang Lai Mun , Fabbri Andrea , Grossman Ashley

Case Report: A 42 year-old male, with a family history of phaeochromocytomas and paragangliomas, was diagnosed as a carrier of the succinate dehydrogenase subunit-B (SDHB) mutation. He was also diagnosed with macroprolactinoma and treated with cabergoline (currently 250 mcg weekly). A contrast CT chest scan, performed as part of the surveillance program for SDHB-associated tumours, revealed a small right lung lesion, which was found to be OctreoScanTM positive. The ...

ea0044p160 | Neuroendocrinology and pituitary | SFEBES2016

Measurement of urinary 5-hydroxyindole acetic acid: correlation between spot vs 24-h urine collection

Calanchini Matilde , Tadman Michael , Krogh Jesper , Fabbri Andrea , Grossman Ashely , Shine Brian

Introduction: In patients with neuroendocrine tumours (NETs), the urinary concentration of the serotonin metabolite 5-hydroxyindole acetic acid (5-HIAA) is used to monitor disease progression or response to treatment. The sensitivity and specificity in the presence of the carcinoid syndrome are approximately 70 and 90%, respectively. However, there are problems with the accurate meaurement of a 24-h collection, and this is often inconvenient for patients. In addition, serotoni...

ea0044p220 | Reproduction | SFEBES2016

Management of Turner’s syndrome women with liver involvement: FIB-4 score is a promising marker of fibrosis

Calanchini Matilde , Moolla Ahmad , Tomlinson Jeremy W , Cobbold Jeremy , Fabbri Andrea , Grossman Ashley , Turner Helen

Introduction: Liver involvement is frequent in Turner’s syndrome (TS). We have shown that 35% TS women have elevated liver function tests (↑LFTs). Most common hepatic changes include steatosis and steatohepatitis; however, progression to advanced fibrosis and cirrhosis is reported. This study assessed a simple noninvasive test for liver fibrosis, FIB-4, which combines standard biochemical values (platelets, ALT, AST) and age in order to evaluate its diagnostic perfo...

ea0041gp65 | Clinical Case Reports | ECE2016

Turner syndrome and liver involvement: is there a place for treatment with ursodeoxycholic acid?

Calanchini Matilde , Moolla Ahmad , Cobbold Jeremy , Tomlinson Jeremy W , Fabbri Andrea , Grossman Ashley , Turner Helen

Introduction: Abnormalities in liver biochemistry are frequent in Turner’s syndrome (TS) with a reported prevalence between 20 and 80%. While their aetiology remains unclear, metabolic factors and intrahepatic biliary disease have been postulated. Moreover, some TS patients have a predominantly cholestatic biochemical abnormality and others a hepatitic picture. Ursodeoxycholic acid (UDCA) has been shown to be a useful treatment of cholestatic disease.<p class="abstext...

ea0041ep209 | Cardiovascular Endocrinology and Lipid Metabolism | ECE2016

Turner’s syndrome and liver involvement: prevalence and characterization of a large population with Turner’s syndrome

Calanchini Matilde , Moolla Ahmad , Tomlinson Jeremy W , Cobbold Jeremy , Fabbri Andrea , Grossman Ashley , Turner Helen

Introduction: Elevated liver function tests (↑LFTs) are frequent in Turner’s syndrome (TS), with a prevalence between 20 and 80%, and increases with age. Their pathogenesis and clinical significance is unclear.Objectives: To study the prevalence of ↑LFTs and their relationship with karyotype, anthropometric, metabolic and TS-related conditions: 68 TS women, average age 39 years (range 18–61 years), were reviewed.<p class="abstex...

ea0059p180 | Reproduction | SFEBES2018

Aortic growth in Turner syndrome is accellerated compared with general population

Calanchini Matilde , Orchard Elizabeth , Bradley-Watson Jason , Fabbri Andrea , Turner Helen E

Introduction: Women with Turner syndrome (TS) have an increased risk of aortic dissection. Aortic dilatation, bicuspid aortic valve (BAV) and hypertension confer increased risk of dissection. However, only some women with these risk factors develop dissection, and others with no risk markers may dissect. Knowledge of the development of the aortopathy over time is limited. We investigate aortic dimension changes in unselected adult TS and associations between aortic growth and ...